The PI3K/Akt/mTOR signaling pathway is a central regulator of cellular processes and is frequently dysregulated in HCC, driving tumor progression, metabolic reprogramming, and therapeutic resistance [20]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.